Type |
Details |
Score |
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; endonuclease-mediated mutation 4, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1, Immunex Research and Development Corporation |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1, Richard M Siegel |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 2.1, Richard M Siegel |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
involves: 129S7/SvEvBrd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a<+> |
Background: |
B6.Cg-Tnfrsf1a |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a<+> |
Background: |
B6.Cg-Tnfrsf1a |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1b; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Efimova EV |
Year: |
2004 |
Journal: |
Oncogene |
Title: |
IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. |
Volume: |
23 |
Issue: |
5 |
Pages: |
1076-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schievella AR |
Year: |
1997 |
Journal: |
J Biol Chem |
Title: |
MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. |
Volume: |
272 |
Issue: |
18 |
Pages: |
12069-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iwasaki K |
Year: |
1997 |
Journal: |
Neuron |
Title: |
aex-3 encodes a novel regulator of presynaptic activity in C. elegans. |
Volume: |
18 |
Issue: |
4 |
Pages: |
613-22 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
MAP kinase-activating death domain protein (MADD) regulates cell proliferation, survival and death through alternative mRNA splicing. Different isoforms have different effects: isoform 5 increases cell proliferation whereas isoform 2 decreases it; isoform 1 is susceptible to inducing apoptosis, isoform 5 is resistant []. MADD activates RAB3A, RAB3C and RAB3D by converting them from GDP-bound inactive forms to GTP-bound active forms []. MADD is a component of the TNFRSF1A signaling complex, linking the type 1 tumor necrosis factor receptor TNFRSF1A with MAP kinase activation []. MADD contains a tripartite DENN domain. In the nematode Caenorhabditis elegans, MADD is also known as regulator of presynaptic activity aex-3 []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Cabal-Hierro L |
Year: |
2012 |
Journal: |
Cell Signal |
Title: |
Signal transduction by tumor necrosis factor receptors. |
Volume: |
24 |
Issue: |
6 |
Pages: |
1297-305 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rittore C |
Year: |
2014 |
Journal: |
Ann Rheum Dis |
Title: |
Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene. |
Volume: |
73 |
Issue: |
1 |
Pages: |
290-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diniz BS |
Year: |
2010 |
Journal: |
J Alzheimers Dis |
Title: |
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. |
Volume: |
22 |
Issue: |
4 |
Pages: |
1305-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hope S |
Year: |
2013 |
Journal: |
Schizophr Res |
Title: |
Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. |
Volume: |
145 |
Issue: |
1-3 |
Pages: |
36-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
EspÃn R |
Year: |
2013 |
Journal: |
Dis Model Mech |
Title: |
TNF receptors regulate vascular homeostasis in zebrafish through a caspase-8, caspase-2 and P53 apoptotic program that bypasses caspase-3. |
Volume: |
6 |
Issue: |
2 |
Pages: |
383-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maier O |
Year: |
2013 |
Journal: |
Biochem Biophys Res Commun |
Title: |
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress. |
Volume: |
440 |
Issue: |
2 |
Pages: |
336-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu X |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. |
Volume: |
192 |
Issue: |
3 |
Pages: |
1320-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tartaglia LA |
Year: |
1993 |
Journal: |
J Biol Chem |
Title: |
Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. |
Volume: |
268 |
Issue: |
25 |
Pages: |
18542-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Speeckaert MM |
Year: |
2012 |
Journal: |
Am J Nephrol |
Title: |
Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. |
Volume: |
36 |
Issue: |
3 |
Pages: |
261-70 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This subfamily of tumor necrosis factor receptor 1A (TNFRSF1, also known as type I TNFR, TNFR1, DR1, TNFRSF1A, CD120a, p55) is found in teleosts. It binds TNF-alpha, through the death domain (DD), and activates NF-kappaB, mediates apoptosis and activates signaling pathways controlling inflammatory, immune, and stress responses. It mediates signal transduction by interacting with antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRAF2 and TRADD that play regulatory roles [, ].Knockout studies in zebrafish embryos have shown that a signaling balance between TNFRSF1A and TNFRSF1B is required for endothelial cell integrity. TNFRSF1A signals apoptosis through caspase-8, whereas TNFRSF1B signals survival via NF-kappaB in endothelial cells. Thus, this apoptotic pathway seems to be evolutionarily conserved, as TNFalpha promotes apoptosis of human endothelial cells and triggers caspase-2 and P53 activation in these cells via TNFRSF1A [].This entry represents the N-terminal domain of TNFR1A from teleosts. TNF-receptors are modular proteins. The N-terminal extracellular part contains a cysteine-rich region responsible for ligand-binding. This region is composed of small modules of about 40 residues containing 6 conserved cysteines; the number and type of modules can vary in different members of the family [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B, also known as TNFR2, type 2 TNFR, TNFBR, TNFR80, TNF-R75, TNF-R-II, p75, CD120b) binds TNF-alpha, but lacks the death domain (DD) that is associated with the cytoplasmic domain of TNFRSF1A (TNFR1) []. It is inducible and expressed exclusively by oligodendrocytes, astrocytes, T cells, thymocytes, myocytes, endothelial cells, and in human mesenchymal stem cells []. TNFRSF1B protects oligodendrocyte progenitor cells (OLGs) against oxidative stress, and induces the up-regulation of cell survival genes []. While pro-inflammatory and pathogen-clearing activities of TNF are mediated mainly through activation of TNFRSF1A, a strong activator of NF-kappaB, TNFRSF1B is more responsible for suppression of inflammation []. Although the affinities of both receptors for soluble TNF are similar, TNFRSF1B is sometimes more abundantly expressed and thought to associate with TNF, thereby increasing its concentration near TNFRSF1A receptors, and making TNF available to activate TNFRSF1A (a ligand-passing mechanism) [].This entry represents the N-terminal domain of TNFR1B. TNF-receptors are modular proteins. The N-terminal extracellular part contains a cysteine-rich region responsible for ligand-binding. This region is composed of small modules of about 40 residues containing 6 conserved cysteines; the number and type of modules can vary in different members of the family [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A, also known as type I TNFR, TNFR1, DR1, CD120a, p55) binds TNF-alpha, through the death domain (DD), and activates NF-kappaB, mediates apoptosis and activates signaling pathways controlling inflammatory, immune, and stress responses. It mediates signal transduction by interacting with antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRAF2 and TRADD that play regulatory roles [, ].The human genetic disorder called tumor necrosis factor associated periodic syndrome (TRAPS), or periodic fever syndrome, is associated with germline mutations of the extracellular domains of this receptor, possibly due to impaired receptor clearance []. TNFRSF1A polymorphisms rs1800693 and rs4149584 are associated with elevated risk of multiple sclerosis []. Serum levels of TNFRSF1A are elevated in schizophrenia and bipolar disorder, and high levels are also associated with cognitive impairment and dementia [, ]. Patients with idiopathic recurrent acute pericarditis (IRAP), presumed to be an autoimmune process, have also been shown to carry rare mutations (R104Q and D12E) in the TNFRSF1A gene [].This entry represents the N-terminal domain of TNFR1A. TNF-receptors are modular proteins. The N-terminal extracellular part contains a cysteine-rich region responsible for ligand-binding. This region is composed of small modules of about 40 residues containing 6 conserved cysteines; the number and type of modules can vary in different members of the family [, , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen G |
Year: |
2002 |
Journal: |
Science |
Title: |
TNF-R1 signaling: a beautiful pathway. |
Volume: |
296 |
Issue: |
5573 |
Pages: |
1634-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ponnuraj EM |
Year: |
2002 |
Journal: |
Clin Exp Immunol |
Title: |
Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. |
Volume: |
128 |
Issue: |
3 |
Pages: |
416-20 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfaip8l1/Tnfaip8l1 Tnfrsf1a/Tnfrsf1a Tnfrsf1b/Tnfrsf1b |
Background: |
C57BL/6-Tnfrsf1b Tnfrsf1a Tnfaip8l1 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Chui YL |
Year: |
2010 |
Journal: |
Biochem Biophys Res Commun |
Title: |
BRE over-expression promotes growth of hepatocellular carcinoma. |
Volume: |
391 |
Issue: |
3 |
Pages: |
1522-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pfeuffer T |
Year: |
2000 |
Journal: |
Cell Microbiol |
Title: |
LaXp180, a mammalian ActA-binding protein, identified with the yeast two-hybrid system, co-localizes with intracellular Listeria monocytogenes. |
Volume: |
2 |
Issue: |
2 |
Pages: |
101-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kwon HJ |
Year: |
2004 |
Journal: |
Mol Cell Biol |
Title: |
Tumor necrosis factor alpha induction of NF-kappaB requires the novel coactivator SIMPL. |
Volume: |
24 |
Issue: |
21 |
Pages: |
9317-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakamura M |
Year: |
2009 |
Journal: |
Br J Dermatol |
Title: |
A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients. |
Volume: |
161 |
Issue: |
4 |
Pages: |
968-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rezaei N |
Year: |
2006 |
Journal: |
Clin Rheumatol |
Title: |
TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder. |
Volume: |
25 |
Issue: |
6 |
Pages: |
773-7 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the death domain (DD) found in tumor necrosis factor receptor-1 (TNFR-1). TNFR-1 has many names including TNFRSF1A, CD120a, p55, p60, and TNFR60. It activates two major intracellular signaling pathways that lead to the activation of the transcription factor NF-kB and the induction of cell death. Upon binding of its ligand TNF, TNFR-1 trimerizes which leads to the recruitment of an adaptor protein named TNFR-associated death domain protein (TRADD) through a DD/DD interaction []. Mutations in the TNFRSF1A gene causes TNFR-associated periodic syndrome (TRAPS), a rare disorder characterized recurrent fever, myalgia, abdominal pain, conjunctivitis and skin eruptions [, ].DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes [, ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents a family of proteins from bacteria, archaea and animals, including Interleukin-1 receptor-associated kinase 1-binding protein 1 from mouse, which has been named SIMPL (signalling molecule that associates with mouse pelle-like kinase). SIMPL is a component of the IRAK1-dependent TNFRSF1A signaling pathway that leads to NF-kappa-B activation and is required for cell survival. It functions by enhancing RelA transcriptional activity [, ]. Separate experiments demonstrate that a mouse family member (named LaXp180) binds the Listeria monocytogenes surface protein ActA, which is a virulence factor that induces actin polymerisation. It may also bind stathmin, a protein involved in signal transduction and in the regulation of microtubule dynamics []. In bacteria its function is unknown, but it is thought to be located in the periplasm or outer membrane. |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi G |
Year: |
2023 |
Journal: |
Cancers (Basel) |
Title: |
TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis. |
Volume: |
15 |
Issue: |
17 |
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
474
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
459
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
474
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
474
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
tumor necrosis factor receptor superfamily, member 1a; targeted mutation 1, Horst Bluethmann |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Vig E |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity. |
Volume: |
276 |
Issue: |
11 |
Pages: |
7859-66 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
259
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
237
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Graham SC |
Year: |
2007 |
Journal: |
J Mol Biol |
Title: |
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. |
Volume: |
372 |
Issue: |
3 |
Pages: |
660-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sedger LM |
Year: |
2006 |
Journal: |
J Virol |
Title: |
Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. |
Volume: |
80 |
Issue: |
18 |
Pages: |
9300-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu FQ |
Year: |
1994 |
Journal: |
Virology |
Title: |
Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. |
Volume: |
204 |
Issue: |
1 |
Pages: |
343-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu X |
Year: |
2000 |
Journal: |
Virus Genes |
Title: |
Myxoma virus expresses a TNF receptor homolog with two distinct functions. |
Volume: |
21 |
Issue: |
1-2 |
Pages: |
97-109 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Viral TNFR homologues include vaccinia virus (VACV) cytokine response modifier E (CrmE) [], an encoded TNFR that shares significant sequence similarity with mammalian type 2 TNF receptors (TNFSFR1B, p75, TNFR type 2) [], a cowpox virus encoded cytokine-response modifier B (CrmB) [], which is a secreted form of TNF receptor that can contribute to the modification of TNF-mediated antiviral processes, and a myxoma virus (MYXV) T2 (M-T2) protein that binds and inhibits rabbit TNF-alpha []. The CrmE structure confirms that the canonical TNFR fold is adopted, but only one of the two "ligand-binding"loops of TNFRSF1A is conserved, suggesting a mechanism for the higher affinity of poxvirusTNFRs for TNFalpha over lymphotoxin-alpha []. CrmB protein specifically binds TNF-alpha and TNF-beta indicating that cowpox virus seeks to invade antiviral processes mediated by TNF. Intracellular M-T2 blocks virus-induced lymphocyte apoptosis via a highly conserved viral preligand assembly domain (vPLAD), which controls receptor signaling competency prior to ligand binding [].This entry represents the N-terminal domain of viral TNFRs. TNF-receptors are modular proteins. The N-terminal extracellular part contains a cysteine-rich region responsible for ligand-binding. This region is composed of small modules of about 40 residues containing 6 conserved cysteines; the number and type of modules can vary in different members of the family [, , ]. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
263
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
232
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, targeted mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, targeted mutation, mutant stock |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, transgenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnf/Tnf Tnfrsf1a/Tnfrsf1a |
Background: |
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
C.129P2-Tnfrsf1a |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
B6.129P2-Tnfrsf1a |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a Tg(Cr2-cre)3Cgn/? |
Background: |
involves: 129P2/OlaHsd * 129S/SvEv |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Gfap-TNF*)K21Gkl/? Tnfrsf1a/Tnfrsf1a<+> |
Background: |
involves: 129P2/OlaHsd * C57BL/6 * CBA |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a Tnfrsf1b/Tnfrsf1b |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Ifng/Ifng Tnfrsf1a/Tnfrsf1a Tnfrsf1b/Tnfrsf1b |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a<+> |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a Tnfrsf1b/Tnfrsf1b |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6NTac |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tnfrsf1a/Tnfrsf1a Tnfrsf1b/Tnfrsf1b Zfp36/Zfp36 |
Background: |
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6NTac |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, spontaneous mutation, targeted mutation |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
454
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
440
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
454
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
454
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
440
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshimura S |
Year: |
2010 |
Journal: |
J Cell Biol |
Title: |
Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. |
Volume: |
191 |
Issue: |
2 |
Pages: |
367-81 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1577
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1627
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1602
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1574
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1577
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1562
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1632
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1573
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1541
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1558
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1115
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1554
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1593
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1475
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Naismith JH |
Year: |
1998 |
Journal: |
Trends Biochem Sci |
Title: |
Modularity in the TNF-receptor family. |
Volume: |
23 |
Issue: |
2 |
Pages: |
74-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bodmer JL |
Year: |
2002 |
Journal: |
Trends Biochem Sci |
Title: |
The molecular architecture of the TNF superfamily. |
Volume: |
27 |
Issue: |
1 |
Pages: |
19-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Banner DW |
Year: |
1993 |
Journal: |
Cell |
Title: |
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. |
Volume: |
73 |
Issue: |
3 |
Pages: |
431-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feinstein E |
Year: |
1995 |
Journal: |
Trends Biochem Sci |
Title: |
The death domain: a module shared by proteins with diverse cellular functions. |
Volume: |
20 |
Issue: |
9 |
Pages: |
342-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park HH |
Year: |
2007 |
Journal: |
Annu Rev Immunol |
Title: |
The death domain superfamily in intracellular signaling of apoptosis and inflammation. |
Volume: |
25 |
|
Pages: |
561-86 |
|
•
•
•
•
•
|